课题基金 / 基金详情

Molecular Biology of Unique Wall Lipids of Mycobacteria

Molecular Biology of Unique Wall Lipids of Mycobacteria
分枝杆菌独特壁脂的分子生物学
批准号:
7004540
负责人:
PAPPACHAN KOLATTUKUDY KOLATTUKUDY
金额:
$28.12万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-09-30 至 2007-12-31

项目摘要

项目成果

PAPPACHAN KOLATTUKUDY KOLATTUKUDY的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):结核病仍然是可预防死亡的主要原因。耐多药结核病的自然传播和恐怖分子可能使用这种菌株,使发现抗分枝杆菌治疗的新靶点成为一项非常迫切的需要。细胞壁脂构成了一种主要的物理和化学防御屏障,帮助病原体逃避宿主的防御和抗分枝杆菌药物。因此,合成对感染至关重要的这种独特的脂类可以成为新的抗分枝杆菌药物的合适靶点。多种甲基支链脂类,如二霉基脂基膦(DIM),已被证明是毒力因子。为了开发新的药物,需要阐明生化反应和参与此类毒力因子生物合成的酶的性质。为此,我们建议:1.阐明脂肪酶基因的功能及其在致病机制中的可能作用,a)表达并鉴定LIP基因产物的催化能力,确定特定LIP基因的中断是否会导致特定类型的脂类或特定的酯化脂肪酸的缺失,并确定突变是否影响毒力,b)直接检测表达的LIP基因产物是否能在体外从表达的合成酶中释放酰链。2.阐明TES基因的生物学功能及其在毒力中的可能作用,a)表达TES基因并鉴定其产物的催化能力,b)。用14C标记的乙酸盐和14C标记的丙酸作为放射性示踪剂,破坏三个TES基因,确定对脂质代谢的影响,并在小鼠模型中确定突变对病原体毒力的影响。3.阐明Wes基因的功能,a)表达Wes基因,并测试这些基因产物是否参与大合成酶产生的甲基支链酸酯化为最终受体的羟基;b)确定干扰Wes基因对脂代谢的影响,并测试表现出新生化表型的突变体的毒力。4.a)阐明新的(催化合成甲基丙二酰辅酶A的酶中的亚基)的作用,该亚基是多个甲基分支毒力因子的构建块,b)确定accD4和accD5的干扰是否影响结核分枝杆菌丙酰-辅酶A的羧化和甲基支链脂质的合成及其毒力。C)确定琥珀酸作为甲基丙二酰辅酶A来源的可能作用。这项研究的结果可能为筛选化学文库提供信息和工具,以发现针对结核分枝杆菌新靶点的新型候选药物,从而帮助抗击耐多药结核病。
英文摘要
DESCRIPTION (provided by applicant): Tuberculosis remains the leading cause of preventable deaths. Natural spread of multidrug resistant tuberculosis and the potential use of such strains by terrorists make discovery of new targets for antimycobacterial therapy a very critical need. Cell wall lipids constitute a major physical and chemical defensive barrier that helps the pathogen evade the host defenses and antimycobacterial drugs. Therefore, synthesis of such unique lipids that are critical for infection can be suitable targets for new antimycobacterial drugs. Multiple methyl branched lipids such as dimycocerosyl phthiocerol (DIM) have been shown to be virulence factors. Elucidation of the biochemical reactions and the nature of the enzymes involved in the biosynthesis of such virulence factors is required for developing novel drags. To this end we propose to: 1. Elucidate the functions of lipase genes and their possible role in pathogenesis, a) Express and characterize the catalytic capabilities of lip gene products and determine whether disruption of specific lip genes will result in the absence of a specific class of acyl-lipids or absence of a specific group of esterified fatty acids, and determine whether the mutations affect virulence, b) Directly test whether the expressed lip gene products can release the acyl chains from the expressed synthases in vitro. 2. Elucidate the biological function of tes genes and their possible role in virulence, a) Express tes genes and characterize the catalytic capabilities of their products, b). Disrupt the three tes genes, determine the effects on lipid metabolism by using 14C-labeled acetate and 14C-labeled propionate as radiotracers and determine the effect of the mutations on virulence of the pathogen in the murine model. 3. Elucidate the function of wes genes, a) Express the wes genes and test whether these gene products are involved in the esterification of the methyl branched acids generated by the large synthases to the hydroxyl groups in the ultimate acceptors, b) Determine the consequences of disrupting the wes genes on lipid metabolism and test the virulence of mutants that show novel biochemical phenotypes. 4. a) Elucidate the role of the novel ( subunit in the enzyme that catalyzes the synthesis of methylmalonyl-CoA, the building block for the multiple methyl branched virulence factors, b) Determine whether disruption of accD4 and accD5 affect propionyl-CoA carboxylation, and methyl branched lipid synthesis in M. tuberculosis and its virulence. c) Determine the possible role of succinate as a source for methylmalonyl-CoA. The results of this study are likely to give information and tools for screening chemical libraries to discover new types of drug candidates directed at novel targets in M. tuberculosis and thus help in combating multidrug resistant tuberculosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MCP-1 induced gene expression in cardiovascular disease
  • 批准号:
    6769538
  • 项目类别:
  • 资助金额:
    $36.0万
  • 财政年份:
    2002
  • 负责人:
    PAPPACHAN KOLATTUKUDY KOLATTUKUDY
  • 依托单位:
MCP-1 induced gene expression in cardiovascular disease
  • 批准号:
    6613833
  • 项目类别:
  • 资助金额:
    $36.0万
  • 财政年份:
    2002
  • 负责人:
    PAPPACHAN KOLATTUKUDY KOLATTUKUDY
  • 依托单位:
MCP-1 induced gene expression in cardiovascular disease
  • 批准号:
    6921433
  • 项目类别:
  • 资助金额:
    $36.0万
  • 财政年份:
    2002
  • 负责人:
    PAPPACHAN KOLATTUKUDY KOLATTUKUDY
  • 依托单位:
MCP-1 induced gene expression in cardiovascular disease
  • 批准号:
    6544149
  • 项目类别:
  • 资助金额:
    $1.0万
  • 财政年份:
    2002
  • 负责人:
    PAPPACHAN KOLATTUKUDY KOLATTUKUDY
  • 依托单位:
国内基金
海外基金
Journal of Integrative Plant Biology
  • 批准号:
    31024801
  • 项目类别:
    专项基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2010
  • 负责人:
    贺萍
  • 依托单位: